Blood News and Research

RSS

Atovaquone "chemical vaccine" for malaria could be more feasible than thought

Johns Hopkins researchers looking to develop a long-acting, injectable malaria preventive using atovaquone have shown in a new study that resistance may not be the challenge scientists thought it was, particularly when using atovaquone as a malaria preventive.

20 Oct 2023

DASH diet may help preserve cognitive function in women later in life

Women with diets during middle age designed to lower blood pressure were about 17 percent less likely to report memory loss and other signs of cognitive decline decades later, a new study finds.

20 Oct 2023

Canine transmission models provide insights into the neurological impacts of COVID-19 on human brains

The histopathologic alteration caused by SARS‑CoV‑2 on mammalian neurological systems.

20 Oct 2023

The beneficial effects of regular physical activity on the cardiovascular profile in the elderly

The effect of regular physical activity (PA) on the microcirculatory functions and plasma antioxidant capacity in older athletes.

20 Oct 2023

18 million British adults at risk of developing diabetes, analysis finds

New analysis from London Medical Laboratory has revealed up to 18 million UK adults could have prediabetes – which means they are on the verge of developing type 2 diabetes. That’s considerably higher than the 7 million figure that is usually quoted.

20 Oct 2023

Do peripheral artery disease risk factors impact men and women differently?

How major risk factors relate to hospitalization or mortality.

20 Oct 2023

Dr. Anthony Lang reveals new model for studying Parkinson’s disease at the 26th World Congress of Neurology

During a plenary lecture at the 26th World Congress of Neurology, Dr. Anthony Lang, professor of neurology and Jack Clark Chair for Parkinson's Disease Research, University of Toronto, revealed a groundbreaking new model for identifying and studying Parkinson’s disease. This new approach will help researchers investigate biological aspects of the disease that may be detectable many years before symptoms begin to show.

20 Oct 2023

Blood pressure variations can raise the risk of dementia and vascular problems in older people

A new study by Australian researchers has shown that fluctuating blood pressure can increase the risk of dementia and vascular problems in older people.

20 Oct 2023

Mediterranean diet intervention may not improve breast cancer prognosis in high-risk patients

Researchers discuss the results of a randomized controlled trial to explore the impact of diet on breast cancer recurrence.

20 Oct 2023

Exploring the impact of solid oat polar lipid-enriched breakfasts on metabolic health

Researchers investigate if oat polar lipid compounds improve glucose tolerance, gut hormonal responses, and triglyceridemia.

20 Oct 2023

First-of-its kind hormone replacement therapy improves symptoms in patients with adrenal conditions

A first-of-its kind hormone replacement therapy that more closely replicates the natural circadian and ultradian rhythms of our hormones has shown to improve symptoms in patients with adrenal conditions.

19 Oct 2023

UCSF dementia experts to join peers at annual Clinical Trials on Alzheimer's disease conference

Dementia experts from UC San Francisco will join their peers from around the globe at the annual Clinical Trials on Alzheimer's Disease (CTAD) conference in Boston from Oct. 24 to 27.

19 Oct 2023

NIH renews support for UMass Chan and UMass Lowell’s point-of-care technology initiative

UMass Chan Medical School and UMass Lowell have received an $8.9 million award from the National Institutes of Health (NIH) for renewed support of their initiative to advance the development of home-based and point-of-care health technologies.

19 Oct 2023

Potato starch supplement may help prevent gvhd in bone marrow transplant patients

Researchers at Baylor College of Medicine and the University of Michigan conducted a phase I pilot study to assess the feasibility of using potato starch as a dietary intervention to modify the gut microbiome in bone marrow transplant patients.

19 Oct 2023

New method uses extracellular vesicles to enhance immunotherapy responses in glioblastoma

A team of researchers at The University of Texas MD Anderson Cancer Center has developed a new method for using extracellular vesicles to enhance responses to immunotherapy in glioblastoma, potentially opening the door for wider use of engineered messenger RNA (mRNA) for cancer therapy.

19 Oct 2023

Stanford Medicine researchers find new way to measure ocular aging

Using a technique they developed for studying eye fluid, Stanford Medicine researchers and their collaborators have found a way to measure ocular aging, opening avenues for treatment of numerous eye diseases.

19 Oct 2023

Oral pathogen linked to increased risk of heart rupture after heart attack

Researchers from Tokyo Medical and Dental University(TMDU) find that a periodontal pathogen, Porphyromonas gingivalis, inhibits autophagosome–lysosome fusion, and can therefore worsen cardiac remodeling and cause cardiac rupture after myocardial infarction.

19 Oct 2023

Lactate-producing intratumoral bacteria drive resistance to radiation therapy

Researchers at The University of Texas MD Anderson Cancer Center have discovered that lactate-producing intratumoral bacteria drives resistance to radiation therapy, suggesting that lactic acid-producing bacteria present in various cancers may serve as novel therapeutic targets.

19 Oct 2023

"Two-for-one" cancer immunotherapy more effective and at least as safe as standard treatments

A "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scientists from UPMC Hillman Cancer Center who led an international, early-phase clinical trial report today in the journal Nature Medicine.

19 Oct 2023

CAR T-cell therapy for multiple myeloma shows no difference in survival outcomes by race and ethnicity

Patients with multiple myeloma treated with idecabtagene vicleucel, known as "ide-cel," a chimeric antigen receptor (CAR) T-cell therapy, had no difference in overall survival outcomes regardless of race and ethnicity, according to a study published in Blood Advances.

19 Oct 2023

Blood News and Research

Atovaquone "chemical vaccine" for malaria could be more feasible than thought

DASH diet may help preserve cognitive function in women later in life

Canine transmission models provide insights into the neurological impacts of COVID-19 on human brains

The beneficial effects of regular physical activity on the cardiovascular profile in the elderly

18 million British adults at risk of developing diabetes, analysis finds

Do peripheral artery disease risk factors impact men and women differently?

Dr. Anthony Lang reveals new model for studying Parkinson’s disease at the 26th World Congress of Neurology

Blood pressure variations can raise the risk of dementia and vascular problems in older people

Mediterranean diet intervention may not improve breast cancer prognosis in high-risk patients

Exploring the impact of solid oat polar lipid-enriched breakfasts on metabolic health

First-of-its kind hormone replacement therapy improves symptoms in patients with adrenal conditions

UCSF dementia experts to join peers at annual Clinical Trials on Alzheimer's disease conference

NIH renews support for UMass Chan and UMass Lowell’s point-of-care technology initiative

Potato starch supplement may help prevent gvhd in bone marrow transplant patients

New method uses extracellular vesicles to enhance immunotherapy responses in glioblastoma

Stanford Medicine researchers find new way to measure ocular aging

Oral pathogen linked to increased risk of heart rupture after heart attack

Lactate-producing intratumoral bacteria drive resistance to radiation therapy

"Two-for-one" cancer immunotherapy more effective and at least as safe as standard treatments

CAR T-cell therapy for multiple myeloma shows no difference in survival outcomes by race and ethnicity

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest News